PHIO
$1.27
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center...
Recent News
BC-Most Active Stocks
CCH Holdings Ltd. 18,962,694 1.32
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
Asian equities traded in the US as American depositary receipts were sharply higher Thursday morning
Phio Reports Tumor Responses in PH-762 Phase 1b Cancer Trial; Shares Surge
Phio Pharmaceuticals (PHIO) said Friday its experimental cancer therapy PH-762 showed a complete pat
Best Value Stocks to Buy for May 28th
PHIO, ALRS and URBN made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 28, 2025.
New Strong Buy Stocks for May 28th
PHIO, FLNG, BWB, ALRS and HALO have been added to the Zacks Rank #1 (Strong Buy) List on May 28, 2025.